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Sharing trial results with participants is an ethical imperative but often does not happen. We
tested an Enhanced Webpage versus a Basic Webpage, Mailed Printed Summary versus
no Mailed Printed Summary, and Email List Invitation versus no Email List Invitation to see
which approach resulted in the highest patient satisfaction with how the results were
communicated.
Methods and findings
We carried out a cluster randomised, 2 by 2 by 2 factorial, nonblinded study within a trial,
with semistructured qualitative interviews with some patients (ISRCTN96189403). Each
cluster was a UK hospital participating in the ICON8 ovarian cancer trial. Interventions were
shared with 384 ICON8 participants who were alive and considered well enough to be con-
tacted, at 43 hospitals. Hospitals were allocated to share results with participants through
one of the 8 intervention combinations based on random permutation within blocks of 8,
stratified by number of participants. All interventions contained a written plain English sum-
mary of the results. The Enhanced Webpage also contained a short video. Both the
Enhanced Webpage and Email contained links to further information and support. The
Mailed Printed Summary was opt-out.
Follow-up questionnaires were sent 1 month after patients had been offered the interven-
tions. Patients’ reported satisfaction was measured using a 5-point scale, analysed by ordi-
nal logistic regression estimating main effects for all 3 interventions, with random effects for
site, restricted to those who reported receiving the results and assuming no interaction.
Data collection took place in 2018 to 2019.
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Questionnaires were sent to 275/384 randomly selected participants and returned by
180: 90/142 allocated Basic Webpage, 90/133 Enhanced Webpage; 91/141 no Mailed
Printed Summary, 89/134 Mailed Printed Summary; 82/129 no Email List Invitation, 98/146
Email List Invitation. Only 3 patients opted out of receiving the Mailed Printed Summary; no
patients signed up to the email list. Patients’ satisfaction was greater at sites allocated the
Mailed Printed Summary, where 65/81 (80%) were quite or very satisfied compared to sites
with no Mailed Printed Summary 39/64 (61%), ordinal odds ratio (OR) = 3.15 (1.66 to 5.98, p
< 0.001). We found no effect on patient satisfaction from the Enhanced Webpage, OR =
1.47 (0.78 to 2.76, p = 0.235) or Email List Invitation, OR = 1.38 (0.72 to 2.63, p = 0.327).
Interviewees described the results as interesting, important, and disappointing (the ICON8
trial found no benefit). Finding out the results made some feel their trial participation had
been more worthwhile. Regardless of allocated group, patients who received results gener-
ally reported that the information was easy to understand and find, were glad and did not
regret finding out the results. The main limitation of our study is the 65% response rate.
Conclusions
Nearly all respondents wanted to know the results and were glad to receive them. Adding an
opt-out Mailed Printed Summary alongside a webpage yielded the highest reported satisfac-
tion. This study provides evidence on how to share results with other similar trial popula-





Why was this study done?
• Previous research has shown that most people who take part in clinical trials want to be
told the results of those trials, but many participants never get to find them out.
• There is little evidence to guide researchers on how best to share results with the people
taking part in their trials.
What did the researchers do and find?
• We carried out a study to test different ways of sharing trial results with participants in
an ovarian cancer trial.
• We randomly assigned hospitals that were part of the ovarian cancer trial to share
results with the women taking part in different ways: a basic webpage or an enhanced
webpage; a printed summary of the results by mail; and an email list to receive the
results.
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• Nine in 10 women wanted to be told the results of the trial they had taken part in.
• Women at hospitals which sent out the printed summary by mail, were more likely to
be satisfied with how the results were shared and were more likely to find out the results
than those at other hospitals.
• Women who received the results said that the information was easy to understand and
find, were glad and did not regret finding out the results.
What do these findings mean?
• These findings suggest that trials with similar participants to our ovarian cancer trial
(mainly women aged 50 or older), where webpages are used to share results with people
taking part, should also share results through opt-out mailed printed summaries.
• This will enable more people who want to know the results to find them out, and
improve satisfaction.
Introduction
Sharing results with people who have taken part in trials is an ethical imperative [1], with the
Declaration of Helsinki saying “All medical research subjects should be given the option of
being informed about the general outcome and results of the study” [2]. Doing this demon-
strates respect for their contribution, with some suggestion that it may increase the likelihood
of participants taking part in future medical research, or recommending taking part in trials to
others [3–7]. Studies have repeatedly shown that, while most participants want to receive
results [3,8–12], many are not offered the opportunity to receive them [13–15].
Trial teams may be uncertain about which method to use for sharing results with partici-
pants. Most of the current evidence is based on surveys of participants or the public, prospec-
tively asking how they would prefer to be informed, or retrospectively asking whether an
approach that was used was acceptable or understandable, rather than systematically compar-
ing outcomes from different approaches [3–6,8,11,12,14,16–21]. Most of the published evi-
dence to date relates to sharing results with participants via mailed letters or leaflets; these
studies generally report high acceptability of this approach [3,5,6,8,9,12,14,17,18,22,23]. How-
ever, sending out results by mail has resource implications. Sharing results via webpages has a
number of potential advantages, including the ability to offer links to further information or
support, and include audio and visual content alongside written summaries, and being discov-
erable by participants who have been lost to follow-up. There are also potential drawbacks in
terms of accessibility for populations with low computer literacy. Fewer studies have reported
sharing results via webpages. Mancini and colleagues randomised participants in a breast can-
cer trial to receive a letter containing a link to a website with the trial results, or no letter. They
found that participants who received the letter had better understanding of the results but
were not significantly more likely to have received the trial results than participants who did
not receive the letter [24]. Other studies have reported low uptake of results shared via web-
pages [14,18], or lower levels of satisfaction with how the results were shared [12]. There is less
evidence around the use of email to share results with participants; however, some studies
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have found that potential research participants would be happy to receive results that way [16].
Other approaches to sharing results that have been reported include face-to-face meetings
[12,18,21], teleconferences [20], and individual telephone calls or helpline services [3,20,22],
although the resource requirements for these approaches may be prohibitive, particularly to
large trials, and uptake of these services may be low, with Dixon-Woods and colleagues report-
ing no calls to a telephone helpline [22].
ICON8 (ISRCTN10356387) was a Phase III randomised controlled trial looking at 3 che-
motherapy regimens for up-front treatment of ovarian cancer. Results from the earlier of the 2
co-primary endpoints, progression-free survival, were published in 2019 [25], showing no dif-
ference in progression-free survival between the 3 regimens. The Show Results to Participants
Engaged in Clinical Trials (Show RESPECT) study (ISRCTN96189403) sought to generate evi-
dence to inform trial teams on how to share results with trial participants through a mixed
methods cluster randomised factorial study within the ICON8 trial. Show RESPECT tested the
following 3 hypotheses, in terms of participant satisfaction with how the results were
communicated:
1. An Enhanced Webpage will be superior to a Basic Webpage;
2. A Mailed Printed Summary sent by post will be superior to no Mailed Printed Summary;
and
3. An invitation to join an Email List to receive updates about the trial results will be superior
to no invitation to join an Email List.
Methods
Show RESPECT was a mixed methods study, comprised of a factorial cluster randomised con-
trolled trial within a trial to assess multiple approaches to communicating trial results, and
embedded explanatory qualitative study. The data collection period for the quantitative and
qualitative components was concurrent. Patients were identified for the semistructured inter-
views from their questionnaire responses and contact form returned alongside the question-
naire, so interviews took place after quantitative data collection for those individuals (while
quantitative data collection continued for others). This paper reports both qualitative and
quantitative results from data collected from trial participants. We consider the qualitative and
quantitative data to have equal weight in their contribution to addressing the research aims.
The full protocol for the study is available online [26] and as S4 Appendix.
We also collected data from site staff, but results from that part of the study are beyond the
scope of this paper.
Ethics approval
The study obtained ethics approval from the London-Chelsea Research Ethics Committee,
MREC number 18/LO/1011.
Patient and public involvement
Substantial patient and public involvement (PPI) was carried out to design and conduct this
study, including focus groups, a PPI survey, patient representation on the study steering
group, and input from patient groups and individuals on the design and content of the
interventions.
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Quantitative methods
Trial design. Show RESPECT was a cluster randomised 2 by 2 by 2 factorial trial within a
host trial, ICON8, an RCT evaluating chemotherapy schedules in ovarian cancer. We rando-
mised each United Kingdom trial site (secondary or tertiary hospital) in ICON8 that agreed to
take part in the Show RESPECT study to a combination of interventions to feedback ICON8
trial results to participants, as shown in Fig 1. A cluster design was chosen for this study, as it
was felt that implementing individual randomisation for sharing results would be impractical
for sites. Each site was a cluster. Allocation to each intervention was on a 1:1 ratio.
Interventions. Participating sites sent all ICON8 patients at those sites a printed Patient
Update Information Sheet thanking them for taking part in ICON8, reminding them of the
aims of the ICON8 trial, informing them that trial results were now available, and how they
could access them. This included the URL of their randomised webpage (Basic or Enhanced).
The Patient Update Information Sheet told patients at sites randomised to the Mailed Printed
Summary that they would be sent a Mailed Printed Summary of the results after 3 weeks and
that they should let their ICON8 site team know if they did not want to be sent this. Patients at
sites randomised to the Email List Invitation were given a URL to sign up to the email list. The
Patient Update Information Sheet was based on guidance from the Health Research Authority
on End of Study Information Sheets [27]. S1 Table contains a detailed description of the study
interventions, and links to the Basic and Enhanced Webpages. The Patient Update Informa-
tion Sheet (S1 Appendix), Mailed Printed Summary (S2 Appendix), and results emails (S3
Appendix) can be found in the Supporting information.
Randomisation 1—All participants in Show RESPECT received a link to either the Basic or
Enhanced Webpage. The Basic Webpage contained a plain English summary of results, using
Fig 1. Show RESPECT trial schema. Diagram showing the 3 randomisations within Show RESPECT: (1) Link to Basic Webpage or Enhanced Webpage; (2) No
Mailed Printed Summary or Mailed Printed Summary; and (3) No invitation to join Email List or Invitation to join Email List.
https://doi.org/10.1371/journal.pmed.1003798.g001
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the structure and headings recommended for lay summaries in the EU database of clinical tri-
als [28]. The Enhanced Webpage used a structure adapted from the Multi-Regional Clinical
Trials Center guidance on feedback of results [29], and included a short video of a doctor
explaining the results, links to further information and support, 2 graphics showing the trial
treatment schedules and main side effects, and the opportunity to submit questions to be
answered in the page’s Frequently Asked Questions (FAQ) section.
Randomisation 2—The Mailed Printed Summary followed the same structure as the
Enhanced Webpage, without the video or FAQ section, and was sent by post to participants’
homes. The Patient Update Information Sheet for sites randomised to no Mailed Printed Sum-
mary told patients that if they were unable to access the webpage or email list, and wanted to
find out the results, they should contact their research nurse.
Randomisation 3—The first email sent to those who signed up to the email list followed the
same structure as the Enhanced Webpage, without the video. Participants were invited to sub-
mit questions about the results, which were answered in subsequent emails.
Participants. Show RESPECT collected data from women with ovarian cancer who had
taken part in the ICON8 trial, were currently still alive, and in follow-up at a site participating
in Show RESPECT. ICON8 participants were not invited to join Show RESPECT if they were
considered by site staff to be too unwell to be contacted about this study.
Outcomes. Our primary outcome measure was participants’ reported satisfaction with
how the results were communicated to them, measured using a 5-point Likert-type scale
(1 = very unsatisfied; 5 = very satisfied). Secondary outcome measures collected from partici-
pants were: the proportion of participants wanting to know the results that did find out; ease
of finding out the results; whether the information about the trial results told participants
everything they wanted to know; ease of understanding the results; how upsetting participants
found the results; willingness to take part in a future trial; likelihood of recommending taking
part in a clinical trial to friends and family; whether participants felt glad to have found out the
results; and whether participants regretted finding out the results. Apart from proportion of
those who wanted to know the results who found them out, these were measured using sepa-
rate 5-point Likert-type scales. Quantitative data were collected from ICON8 participants by a
questionnaire sent by site staff to their home address.
Data were collected between December 2018 to September 2019. Data collection finished 4
months after the final randomisation as it was felt that longer follow-up would run the risk of
participants being unable to recall their experience of receiving results accurately.
Sample size. At trial sites, the allocated Show RESPECT intervention was offered to all eli-
gible ICON8 participants (through the Patient Update Information Sheet). However, we did
not approach all eligible participants for data collection, so as to reduce the burden on partici-
pants and staff, and because in cluster randomised trials the marginal information value of
each participant declines as cluster size increases [30]. Specifically, at small sites (�5 eligible
participants), all eligible participants were invited to provide outcome data, but at medium
sites (6 to 12), we aimed to collect outcome data from 6 participants, and from large sites
(�13), we aimed to collect data from 12. For medium and large sites, the individuals invited to
participate were selected at random centrally. At medium and large sites, if a participant who
was invited to take part chose not to, we invited the next participant from a randomly ordered,
centrally held list to take part to replace the original participant, until the target number of par-
ticipants at that site was reached, or no eligible participants remained.
The primary outcome measure was ordinal but for simplicity, because of lack of knowledge
of its likely distribution, and to be scientifically conservative, we considered it as a binary out-
come for our power calculations. We anticipated that the proportion of respondents “satisfied”
without any of the research interventions would be between 20% and 80%, and in the absence
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of specific prior information considered values of the Intracluster Correlation Coefficient
(ICC) between 0.01 and 0.05. We considered power to detect an effect for any of the 3 inter-
ventions, for simplicity considering each in turn, i.e., effectively conducting a power calcula-
tion for each intervention assuming the other two would have no effect. We also assumed no
appreciable interactions between the 3 interventions. We calculated that, based on 21 sites
with and without an intervention, and an average of 4 respondents per site (172 in total), at an
ICC of 0.01, we would have 80% power to detect an increase from 20% to 40%, from 50% to
71%, or from 80% to 95% in the satisfied group. Should the ICC be 0.05, then this sample size
would have provided 80% power to detect an increase from 20% to 42%, 50% to 73%, or 80%
to 95%. Calculations were conducted in Stata using the “power two proportions” command
and assumed a coefficient of variation in cluster size of 0.6. No power calculations were made
for the secondary outcomes.
Randomisation. Sites were randomised in blocks of 8 (the number of allocation arms
available) once sites had obtained the necessary approvals. In the first phase, we randomised 3
blocks each of one site size (small, medium, and large), but, subsequently, blocks were of
mixed sizes. Randomisation was conducted through random permutation within blocks.
To ensure allocation blinding, although the Show RESPECT trial statistician generated the
allocations for the blocks and was aware of which clinics featured in each block, a second stat-
istician unaware of these allocations randomly permuted the clinic names within blocks. The
allocations and clinic names for each block were then matched together by a third party and
revealed to the trial team. Sites were informed of their randomised allocation and sent the
matching Patient Update Information Sheet.
Clusters were recruited between September 2018 to May 2019. Sites were randomised
between November 2018 to May 2019. The trial was registered in February 2019, which was
after some sites had been randomised, due to human resource constraints.
Blinding. Once randomisation had been performed, it was not possible to blind site staff
to the allocation of their site. ICON8 participants were not informed that the way they were
being offered the results was determined by randomisation and were not aware of the inter-
ventions being offered to participants at other sites. The questionnaire contained an embedded
informed consent element, in line with the UK Health Research Authority’s guidance on pro-
portionate approaches to informed consent for self-administered questionnaire-based research
[31], with completion and return of the questionnaire taken to indicate consent to use the data
has been given.
Statistical analysis. The full statistical analysis plan can be found in S5 Appendix. The
primary outcome measure was defined only for participants who received the ICON8 trial
results, and hence analysis for this outcome was restricted to participants who reported receiv-
ing the ICON8 results. For this reason, we describe the primary analysis as following modified
intention to treat (mITT). All other secondary outcomes are similarly only defined for partici-
pants who received the ICON8 results, with the exception of “report finding out the ICON8
results,” which we present separately among participants who report they wanted to find the
results out, and among participants who report they did not. To assess the overall effect of the
intervention, it is important to interpret the results of the primary analysis alongside results
concerning the possible effect of the interventions on whether participants actually found out
the ICON8 results.
In the ICON8 setting, participants’ health may be poor and may deteriorate before the
Show RESPECT interventions were received or between intervention exposure and follow-up
by questionnaire. Participants who died or became too sick to complete a questionnaire were
not considered “eligible” for data collection or analysis and were not considered as missing
data.
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There was no specific prior evidence to suggest whether or not there would be interactions
between the interventions. We were unable to think of a mechanism for potential interactions,
so designed the trial based on the assumption that the effect of each intervention (e.g.,
enhanced versus basic webpage) would not be substantially affected by whether or not the par-
ticipant was allocated to the other interventions. Hence, the primary analysis was of the main
effects of each intervention adjusting for the others. However, for the primary outcome mea-
sure, we also tested each of the 3 two-way interactions and report the effect of each of 7 inter-
vention combinations relative to control (Basic Webpage only). Adjustments were not made
for multiple testing as we view our 3 study hypotheses as distinct, so all confidence intervals
(CIs) presented are at the standard 5% significance level.
To reflect the study design, we adjusted for site size stratum, and also first phase versus later
randomisation phases. All models included random effects for site. Estimates were also
adjusted for age (continuous–linear), education (graduate versus not), and internet use (daily
versus less).
Effect measures for the interventions are estimated and presented based on regression mod-
els. Ordinal random effects logistic regression was used for the primary and other Likert-type
scale outcomes unless the proportional odds assumption was clearly violated. Consider odds
ratios (ORs) in relation to each way the outcome could be dichotomised, e.g., quite unsatisfied
or better versus very unsatisfied, quite or very satisfied versus neither or worse. Under the pro-
portional odds assumption, these ORs are all equal, and their common value is estimated
through ordinal logistic regression. The response categories were merged for the regression
analysis in the event of very low reporting of one or more categories (<5% of responses). All
decisions about merging response categories were taken based on an initial dataset without
cluster or allocation identifiers.
For the primary outcome measure only, we conducted prespecified subgroup analyses by
age group (�70 versus�71 years), allocated arm of the ICON8 trial, education category (grad-
uate versus not), and reported internet use (daily versus not). For each subgroup analysis, the
effect of each intervention within subgroups were presented, and an interaction test was con-
ducted. All interactions were with binary subgroups, with the exception of age, which was used
as a continuous variable. These subgroup analyses were conducted for each of the 3 interven-
tions separately.
Statistical analyses were performed using Stata version 16.1 (Stata Corp, Texas).
Qualitative methods
Qualitative data collection. Semistructured interviews were carried out with participants
either face-to-face (at the participant’s home or other location chosen by them) or by tele-
phone by the lead qualitative researcher, AS, who holds an MPhil and MSc, is a research com-
munication specialist, is female, and has been trained in qualitative research methods. The
interviews were informed by a topic guide (S1 Text), which was informed by PPI. The inter-
viewer is a research communicator by profession and was involved in developing the interven-
tions tested in Show RESPECT. The topic guide was amended as interviews proceeded to
follow-up on issues that emerged in early interviews and to improve clarity [32]. Only the par-
ticipant and interviewer were present during the interviews. No repeat interviews were carried
out. Interviews lasted between 32 minutes to 102 minutes. The interviews were audio recorded,
and field notes were made immediately after the interviews. The interviews were transcribed
verbatim. The transcriptions were checked back against the recordings for accuracy, and any
identifying data were redacted. Transcripts were not returned to participants. Free-text ques-
tions within the questionnaire were also used to collect qualitative data.
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Sampling. Invitations to take part in interviews were sent out with the Show RESPECT
questionnaire, with participants asked to complete a contact details form if they wanted to find
out more about the interviews and return it alongside their questionnaire. Purposive sampling
was carried out, based on their questionnaire responses, to include people offered the range of
Show RESPECT interventions, different levels of satisfaction with how the results were com-
municated, education level, internet usage, and age. Respondents who completed the contact
details form and filled one or more gaps in the sampling frame were contacted by telephone
with more information about the study and, if they were willing to take part, a time and date
was arranged for the interview. Participants gave written informed consent. Interviews were
carried out until all the gaps in the sampling frame were filled, or until no more volunteers
were available who would fill a gap in the sampling frame. Using the Information Power
model [33] to assess the necessary sample size, the study aim was reasonably narrow, focusing
on just one aspect of trial experience (receiving results), although it did look at several
approaches to results communication. The sample specificity was dense, with all interviewees
having highly relevant experiences. As described in the analysis section below, an established
model was applied during the analysis. The quality of dialogue in most interviews was good,
resulting in a rich dataset. The analysis strategy was cross-case. Taken together, these factors
suggest that a moderate sample size should provide sufficient information power to meet the
aims of the study.
Qualitative analysis. The first step of analysis was familiarisation with the data, by listen-
ing to the recordings and reading the transcripts a number of times, recording ideas for initial
codes. A thematic analysis approach was employed [34]. Both inductive and deductive
approaches were for coding the data, which was carried out by AS. Initial codes were then
grouped into potential themes. Emerging themes were discussed with staff from the ICON8
and Show RESPECT trial management teams. As analysis proceeded, it was found that the
Information-seeking and Communication Model (ISCM) [35] fitted the codes well, so codes
were categorised using concepts from that model. The ISCM is a model of information behav-
iour that covers both information users and information providers, their contexts, the activi-
ties of information seeking, information use and communication, and the factors that affect
them [36]. Network diagrams were produced to visualise links between codes within themes,
and themes were reviewed in relation to the coded extracts. As themes were generated, we
searched for cases which did not fit the existing structure. Inductive thematic saturation was
reached at the 13th interview, as was data saturation. Participant checking did not take place,
but a PPI discussion group was held to reflect on the emerging findings and interpretation.
Analysis was conducted in Atlas.ti version 8.4 (ATLAS.ti Scientific Software Development
GmbH).
A “following the thread” approach was used to triangulate the results of the qualitative and
quantitative components of the study [37]. This was done at the analysis stage. Each data set
was initially analysed using approaches applicable to the type of data to identify key themes
and questions. The qualitative data were then interrogated to explore issues raised in the quan-
titative data (following the “thread” from one dataset to the other).
Results
Participation in Show RESPECT
Fig 2 shows the CONSORT diagram for the study. The 83 ICON8 sites in the UK were
assessed for eligibility. Approximately 40 sites were excluded for reasons including lack of
ICON8 participants eligible for Show RESPECT (5), lack of capacity (6), declining to take part
(4), failing to obtain site approvals in time (12), or nonresponse to the invitation (13). About
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43 (52%) ICON8 UK sites took part in Show RESPECT. Table 1 shows the number of sites
randomised to the interventions by site size strata, number of eligible participants who were
offered the interventions, sent the questionnaire, and returned the questionnaire. Data collec-
tion took place between December 2018 and September 2019. In total, 384 ICON8 participants
were offered the Show RESPECT interventions; 275 were sent the questionnaire of which 182
questionnaires were returned from 180 participants (65%) (2 of the 182 returned question-
naires were duplicates so not analysed).
Delivery of the interventions. Logs kept by sites showed that Patient Update Information
Sheets went to 100% of eligible ICON8 participants at participating sites. Three ICON8 partici-
pants opted out of receiving the Mailed Printed Summary. According to site logs, all other eli-
gible ICON8 participants at sites randomised to Mailed Printed Summaries were sent them.
Baseline characteristics of participants. Table 2 shows the baseline characteristics of
those who returned the questionnaire, and S2 Table shows the baseline characteristics of all
eligible ICON8 participants at Show RESPECT sites. The mean age of participants who
returned the questionnaire was 67, with approximately one-third from each of the 3 ICON8
arms. There was a wide range of reported highest level of educational attainment, with 38
(21%) reporting no qualifications, and 41 (23%) holding a degree or higher qualification.
Nearly all participants who returned the questionnaire reported English being their first
Fig 2. CONSORT diagram for Show RESPECT. CONSORT diagram showing flow of sites and participants through the Show RESPECT study.
https://doi.org/10.1371/journal.pmed.1003798.g002
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language. About 61 (40%) respondents reported using the internet or email less frequently
than every day, with 26 (15%) never using internet or email.
About 94 participants were invited to take part in the qualitative study, and 13 (14%) were
interviewed. Table 3 shows the characteristics of the interviewed participants. The parts of the
sampling frame we were unable to recruit participants for were “opted out of Mailed Printed
Summary,” “had used the email list,” and “aged 50 or younger.”
Primary outcome: Did the interventions improve satisfaction with how the
results were shared?
Quantitative findings on satisfaction with how the results were shared. Tables 4–6
shows the patient-reported outcomes relating to the experience of receiving the results, by ran-
domised intervention. For the primary outcome of participant satisfaction with how the results
were communicated, among the 3 interventions, only the Mailed Printed Summary led to a
significant improvement (adjusted OR 3.15, 95% CI 1.66 to 5.98, p< 0.001). The effect sizes
for the Enhanced versus Basic Webpages (adjusted OR 1.47, 95% CI 0.78 to 2.76, p = 0.235)
and Email List Invitation (adjusted OR 1.38, 95% CI 0.72 to 2.63, p = 0.327) were much
Table 1. Recruitment of sites and participants to Show RESPECT, by site size1.
Overall Webpage Mailed Printed Summary Email List Invitation













TOTAL 43 (100) 22 21 21 22 21 22
Small sites 17 (40) 8 (36) 9 (43) 8 (38) 9 (41) 9 (43) 8 (36)
Medium sites 13 (30) 7 (32) 6 (29) 6 (29) 7 (32) 6 (29) 7 (32)
Large sites 13 (30) 7 (32) 6 (29) 7 (33) 6 (27) 6 (29) 7 (32)
Number of eligible participants (offered interventions)
TOTAL 384 190 194 201 183 157 227
Small sites 54 (14) 24 (13) 30 (15) 27 (13) 27 (15) 32 (20) 22 (10)
Medium sites 76 (20) 45 (24) 31 (16) 37 (18) 39 (21) 35 (22) 41 (18)
Large sites 254 (66) 121 (64) 133 (69) 137 (68) 117 (64) 90 (57) 164 (72)
Number of participants sent the questionnaire
TOTAL 275 142 133 141 134 129 146
Small sites 53 (19) 24 (17) 29 (22) 26 (18) 27 (20) 31 (24) 22 (15)
Medium sites 67 (24) 40 (28) 27 (20) 30 (21) 37 (28) 33 (26) 34 (23)
Large sites 155 (56) 78 (55) 77 (58) 85 (60) 70 (52) 65 (50) 90 (62)
Number of participants who returned the questionnaire (number analysed)
TOTAL 180 90 90 91 89 82 98
Small sites 40 (22) 15 (17) 25 (28) 21 (23) 19 (21) 21 (26) 19 (19)
Medium sites 49 (27) 30 (33) 19 (21) 23 (25) 26 (29) 26 (32) 23 (23)
Large sites 91 (51) 45 (50) 46 (51) 47 (52) 44 (49) 35 (43) 56 (57)
Response rate (percent of questionnaires sent that were returned)
TOTAL 65% 63% 68% 65% 66% 64% 67%
Small sites 75% 63% 86% 81% 70% 68% 86%
Medium sites 73% 75% 70% 77% 70% 79% 68%
Large sites 59% 58% 60% 55% 63% 54% 62%
1Small sites had 5 or fewer ICON8 patients, medium sites 6–12 ICON8 patients, and large sites 13 or more ICON8 patients alive at the time of the site agreeing to be
part of Show RESPECT.
https://doi.org/10.1371/journal.pmed.1003798.t001
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smaller. Furthermore, there was no evidence of interaction between any pair of interventions
(interaction between webpage and printed summary p = 0.161, webpage and email p = 0.624,
printed summary and email p = 0.995).
There was no evidence of heterogeneity of the effects of the interventions on the primary
outcome by age, arm in ICON8, education, or reported frequency of internet or email use (S3
Table and S1 Fig). When the 8 possible combinations of interventions were looked at individ-
ually, only those that contained the Mailed Printed Summary significantly improved the odds
of participants reporting being satisfied with how the results were communicated (S4 Table).
Qualitative findings on the reasons for satisfaction. S5 Table contains a description of
the categories from the qualitative data. Participants cited many reasons for their reported sat-
isfaction, including characteristics related to the information products (clear and understand-
able); ease of accessing the results; receiving results in their preferred way; the process by
which they received results (the Patient Update Information Sheet being sent out first to give
them options); and their reflections on the emotional impact of the results and perceived
impact for others. Participants who were unsatisfied with how the results were shared (16% of
questionnaire respondents) cited a number of reasons, including the following: not knowing
how to find out the results; problems accessing the webpage; finding the results difficult to
understand; preferring to have found out the results in a different way (for example, wanting a
Table 2. Baseline characteristics of participants who returned the questionnaire.




















Mean (IQR) 67 (61–74) 68 (62–74) 67 (61–74) 68 (62–74) 68 (63–75) 67 (61–73) 67 (62–
74)
�70 years 52 (58) 51 (57) 52 (57) 51 (57) 43 (52) 60 (61) 103 (57)
>70 years 38 (42) 39 (43) 39 (43) 38 (43) 39 (48) 38 (39) 77 (43)
ICON8 arm
Standard treatment 26 (29) 31 (34) 29 (32) 28 (31) 25 (30) 32 (33) 57 (32)
Dose fractionated paclitaxel 33 (37) 28 (31) 32 (35) 29 (33) 28 (34) 33 (34) 61 (34)
Dose fractionated carboplatin and paclitaxel 31 (34) 31 (34) 30 (33) 32 (36) 29 (35) 33 (34) 62 (34)
Highest level of educational attainment
No qualifications 14 (16) 24 (27) 25 (27) 13 (15) 19 (23) 19 (20) 38 (21)
GCSE or equivalent 28 (31) 29 (33) 26 (29) 31 (36) 32 (40) 25 (26) 57 (32)
A-level or equivalent 25 (28) 17 (19) 18 (20) 24 (28) 17 (21) 25 (26) 42 (24)
Undergraduate degree 11 (12) 13 (15) 11 (12) 13 (15) 8 (10) 16 (16) 24 (13)
Postgraduate degree 11 (12) 6 (7) 11 (12) 6 (7) 5 (6) 12 (12) 17 (10)
English as first language
Yes 82 (93) 90 (100) 85 (96) 87 (98) 78 (98) 94 (96) 172 (97)
No 6 (7) 0 (0) 4 (4) 2 (2) 2 (3) 4 (4) 6 (3)
Use of internet or email
Never 17 (19) 9 (10) 13 (14) 13 (15) 11 (13) 15 (15) 26 (15)
Once per month at most 3 (3) 4 (4) 4 (4) 3 (3) 6 (7) 1 (1) 7 (4)
More than once per month, but not as often as
every week
1 (1) 10 (11) 6 (7) 5 (6) 0 (0) 11 (11) 11 (6)
Once per week or more, but not as often as every
day
10 (11) 17 (19) 15 (17) 12 (13) 16 (20) 11 (11) 27 (15)
Every day 58 (65) 50 (56) 52 (58) 56 (63) 49 (60) 59 (61) 108 (60)
https://doi.org/10.1371/journal.pmed.1003798.t002
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more personal approach, such as being told the results in person or by telephone); perceived
lack of timeliness in receiving the results; and the information not giving enough detail.
Did patients want the results, and did they find them out?
Nearly all participants (164/177 (93%)) reported wanting to know the results, and 145 (88%) of
these 164 reported finding out the results. None of the participants who reported not wanting
to know the results reported having found them out. These 13 participants were spread across
the Show RESPECT interventions.
Table 3. Characteristics of qualitative interviewees.
Characteristics No. of interviewees




Mailed Printed Summary 6
No Mailed Printed Summary 7
Email List Invitation 9




Mailed Printed Summary 6
Opted out of Mailed Printed Summary 0
Email list 0
Had not found out the results prior to interview 2
Reported satisfaction with how the results were shared (from quantitative questionnaire)3
Very unsatisfied, quite unsatisfied, or neither satisfied nor unsatisfied 5
Quite satisfied or very satisfied 5
Reported highest level of education4
A levels or lower 6
Degree or higher 6
Reported frequency of internet/email use
Less than once a week 2
More than once a week 11
ICON8 randomised allocation
Three-weekly chemotherapy (control arm) 3






1Adds up to >13 as some participants were offered more than one intervention.
2Adds up to >13 as some participants used more than one intervention.
3Data missing from 3 participants’ questionnaires.
4Data missing from 1 participant’s questionnaire.
https://doi.org/10.1371/journal.pmed.1003798.t003
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Table 4. Reported outcomes relating to experience of receiving the results by randomised intervention: Enhanced versus Basic Webpage.
Basic Webpage n. (%) Enhanced Webpage n. (%) uOR1 (95% CI) p-value aOR2 (95% CI) p-value Overall n (%)
Proportion of patients who reported finding out the
results
Number for whom data were available for this outcome: 180
Wanted results 71 (89) 74 (88) 0.85 (0.31 to 2.32) p = 0.753 0.91 (0.33 to 2.54) p = 0.864 145 (88)
Did not want results 0 0 0 (0)
Reported satisfaction with how the results were
communicated (primary outcome)
Number for whom data were available for this outcome: 145
Very unsatisfied 6 (9) 6 (8) 1.39 (0.75 to 2.59) p = 0.295 1.47 (0.78 to 2.76) p = 0.235 12 (8)
Quite unsatisfied 8 (12) 4 (5) 12 (8)
Neither 11 (16) 6 (8) 17 (12)
Quite satisfied 16 (23) 24 (32) 40 (28)
Very satisfied 28 (41) 36 (47) 64 (44)
The information told me everything I wanted to know3 Number for whom data were available for this outcome: 146
Strongly disagree 0 (0) 3 (4) 2.13 (1.13 to 4.00) p = 0.019 2.15 (1.13 to 4.07) p = 0.019 3 (2)
Slightly disagree 5 (7) 2 (3) 7 (5)
Neither 16 (23) 10 (13) 26 (18)
Slightly agree 21 (30) 13 (17) 34 (23)
Strongly agree 28 (40) 48 (63) 76 (52)
The information was easy to understand3 Number for whom data were available for this outcome: 146
Strongly disagree 2 (3) 4 (5) 0.92 (0.47 to 1.81) p = 0.817 1.05 (0.53 to 2.08) p = 0.895 6 (4)
Slightly disagree 4 (6) 1 (1) 5 (3)
Neither 10 (14) 8 (11) 18 (12)
Slightly agree 10 (14) 16 (21) 26 (18)
Strongly agree 44 (63) 47 (62) 91 (62)
It was easy to find the trial results Number for whom data were available for this outcome: 144
Strongly disagree 5 (7) 3 (4) 1.34 (0.71 to 2.53) p = 0.373 1.75 (0.90 to 3.42) p = 0.100 8 (6)
Slightly disagree 5 (7) 4 (5) 9 (6)
Neither 14 (21) 7 (9) 21 (15)
Slightly agree 8 (12) 19 (25) 27 (19)
Strongly agree 36 (53) 43 (57) 79 (55)
I am glad I found out the trial results4 Number for whom data were available for this outcome: 145
Strongly disagree 0 (0) 2 (3) 0.79 (0.38 to 1.65) p = 0.533 0.84 (0.40 to 1.75) p = 0.638 2 (1)
Slightly disagree 1 (1) 1 (1) 2 (1)
Neither 7 (10) 7 (9) 14 (10)
Slightly agree 12 (17) 13 (17) 25 (17)
Strongly agree 50 (71) 52 (69) 102 (70)
I regret finding out the trial results5 Number for whom data were available for this outcome: 138
Strongly disagree 53 (79) 48 (68) 1.51 (0.74 to 3.01) p = 0.253 1.41 (0.68 to 2.92) p = 0.354 101 (73)
Slightly disagree 3 (4) 9 (13) 12 (9)
Neither 9 (13) 12 (17) 21 (15)
Slightly agree 2 (3) 1 (1) 3 (2)
Strongly agree 0 (0) 1 (1) 1 (1)
I found the results upsetting Number for whom data were available for this outcome: 140
Strongly disagree 40 (59) 35 (49) 1.26 (0.66 to 2.41) p = 0.485 1.24 (0.65 to 2.39) p = 0.514 75 (54)
Slightly disagree 5 (7) 7 (10) 12 (9)
Neither agree nor disagree 11 (16) 19 (26) 30 (21)
Slightly agree 7 (10) 9 (13) 16 (11)
Strongly agree 5 (7) 2 (3) 7 (5)
1Adjusted for strata, randomisation phase (early vs late), and clustering.
2Adjusted for age, education level, and internet use as well as strata, randomisation phase (early vs late), and clustering.
3For producing the ORs for this variable, the strongly and slightly disagree categories were merged.
4For calculating the ORs, the strongly disagree, slightly disagree, and neither agree nor disagree categories were merged for this variable.
5For calculating the ORs, the neither agree nor disagree, slightly agree, and strongly agree categories were merged for this variable.
aOR, adjusted OR; OR, odds ratio; uOR, unadjusted OR.
https://doi.org/10.1371/journal.pmed.1003798.t004
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Table 5. Reported outcomes relating to experience of receiving the results by randomised intervention: Mailed Printed Summary versus no Mailed Printed
Summary.
No Mailed Printed Summary n. (%) Mailed Printed Summary n.(%) uOR1 (95% CI) p-value aOR2 (95% CI) p-value Overall n (%)
Proportion of patients who reported finding out the results Number for whom data were available for this outcome: 180
Wanted results 67 (83) 78 (94) 3.27 (1.10 to 9.70) p = 0.032 3.57 (1.18 to 10.77) p = 0.024 145 (88)
Did not want results 0. 0 0 (0)
Reported satisfaction with how the results were communicated
(primary outcome)
Number for whom data were available for this outcome: 145
Very unsatisfied 6 (9) 6 (7) 3.27 (1.74 to 6.16) p < 0.001 3.15 (1.66 to 5.98) p< 0.001 12 (8)
Quite unsatisfied 7 (11) 5 (6) 12 (8)
Neither 12 (19) 5 (6) 17 (12)
Quite satisfied 23 (36) 17 (21) 40 (28)
Very satisfied 16 (25) 48 (59) 64 (44)
The information told me everything I wanted to know3 Number for whom data were available for this outcome: 146
Strongly disagree 0 (0) 3 (4) 1.32 (0.70 to 2.46) p = 0.391 1.32 (0.70 to 2.48) p = 0.394 3 (2)
Slightly disagree 1 (2) 6 (7) 7 (5)
Neither 15 (23) 11 (14) 26 (18)
Slightly agree 20 (31) 14 (17) 34 (23)
Strongly agree 29 (45) 47 (58) 76 (52)
The information was easy to understand4 Number for whom data were available for this outcome: 146
Strongly disagree 2 (3) 4 (5) 1.60 (0.82 to 3.11) p = 0.167 1.66 (0.84 to 3.27) p = 0.144 6 (4)
Slightly disagree 4 (6) 1 (1) 5 (3)
Neither 10 (14) 8 (11) 18 (12)
Slightly agree 10 (14) 16 (21) 26 (18)
Strongly agree 44 (63) 47 (62) 91 (62)
It was easy to find the trial results Number for whom data were available for this outcome: 144
Strongly disagree 3 (5) 5 (6) 1.15 (0.61 to 2.18) p = 0.662 1.37 (0.71 to 2.66) p = 0.345 8 (6)
Slightly disagree 7 (11) 2 (3) 9 (6)
Neither 6 (9) 15 (19) 21 (15)
Slightly agree 14 (22) 13 (16) 27 (19)
Strongly agree 34 (53) 45 (56) 79 (55)
I am glad I found out the trial results5 Number for whom data were available for this outcome: 145
Strongly disagree 0 (0) 2 (3) 1.69 (0.81 to 3.50) p = 0.161 1.69 (0.81 to 3.53) p = 0.162 2 (1)
Slightly disagree 0 (0) 2 (3) 2 (1)
Neither 9 (14) 5 (6) 14 (10)
Slightly agree 14 (21) 11 (14) 25 (17)
Strongly agree 43 (65) 59 (75) 102 (70)
I regret finding out the trial results6 Number for whom data were available for this outcome: 138
Strongly disagree 45 (70) 56 (76) 0.93 (0.46 to 1.88) p = 0.850 0.94 (0.46 to 1.91) p = 0.856 101 (73)
Slightly disagree 7 (11) 5 (7) 12 (9)
Neither 10 (16) 11 (15) 21 (15)
Slightly agree 2 (3) 1 (1) 3 (2)
Strongly agree 0 (0) 1 (1) 1 (1)
I found the results upsetting Number for whom data were available for this outcome: 140
Strongly disagree 35 (55) 40 (53) 1.21 (0.64 to 2.30) p = 0.564 1.31 (0.68 to 2.51) p = 0.421 75 (54)
Slightly disagree 6 (9) 6 (8) 12 (9)
Neither agree nor disagree 15 (23) 15 (20) 30 (21)
Slightly agree 8 (13) 8 (11) 16 (11)
Strongly agree 0 (0) 7 (9) 7 (5)
1Adjusted for strata, randomisation phase (early vs late), and clustering.
2Adjusted for age, education level, and internet use as well as strata, randomisation phase (early vs late), and clustering.
3For producing the ORs for this variable, the strongly and slightly disagree categories were merged.
4For producing the ORs for this variable, the strongly and slightly disagree categories were merged.
5For calculating the ORs, the strongly disagree, slightly disagree, and neither agree nor disagree categories were merged for this variable.
6For calculating the ORs, the neither agree nor disagree, slightly agree, and strongly agree categories were merged for this variable.
aOR, adjusted OR; OR, odds ratio; uOR, unadjusted OR.
https://doi.org/10.1371/journal.pmed.1003798.t005
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Table 6. Reported outcomes relating to experience of receiving the results by randomised intervention: Email List Invitation versus no Email List Invitation.
No Email List Invitation n. (%) Email List Invitation n. (%) uOR1 (95% CI) p-value aOR2 (95% CI) p-value Overall n (%)
Proportion of patients who reported finding out the results Number for whom data were available for this outcome: 180
Wanted results 65 (88) 80 (89) 0.96 (0.35 to 2.61) p = 0.935 0.78 (0.27 to 2.22) p = 0.641 145 (88)
Did not want results 0 0 0 (0)
Reported satisfaction with how the results were communicated
(primary outcome)
Number for whom data were available for this outcome: 145
Very unsatisfied 8 (12) 4 (5) 1.33 (0.71 to 2.47) p = 0.373 1.38 (0.72 to 2.63) p = 0.327 12 (8)
Quite unsatisfied 8 (12) 4 (5) 12 (8)
Neither 8 (12) 9 (11) 17 (12)
Quite satisfied 13 (20) 27 (34) 40 (28)
Very satisfied 29 (44) 35 (44) 64 (44)
The information told me everything I wanted to know3 Number for whom data were available for this outcome: 146
Strongly disagree 1 (1) 2 (3) 1.12 (0.60 to 2.10) p = 0.728 1.11 (0.58 to 2.12) p = 0.759 3 (2)
Slightly disagree 3 (4) 4 (5) 7 (5)
Neither 13 (19) 13 (16) 26 (18)
Slightly agree 16 (24) 18 (23) 34 (23)
Strongly agree 34 (51) 42 (53) 76 (52)
The information was easy to understand3 Number for whom data were available for this outcome: 146
Strongly disagree 2 (3) 4 (5) 0.85 (0.43 to 1.66) p = 0.627 0.79 (0.39 to 1.59) p = 0.500 6 (4)
Slightly disagree 3 (4) 2 (3) 5 (3)
Neither 8 (12) 10 (13) 18 (12)
Slightly agree 10 (15) 16 (20) 26 (18)
Strongly agree 44 (66) 47 (59) 91 (62)
It was easy to find the trial results Number for whom data were available for this outcome: 144
Strongly disagree 5 (8) 3 (4) 0.81 (0.42 to 1.54) p = 0.511 0.70 (0.36 to 1.38) p = 0.306 8 (6)
Slightly disagree 4 (6) 5 (6) 9 (6)
Neither 6 (9) 15 (19) 21 (15)
Slightly agree 11 (17) 16 (20) 27 (19)
Strongly agree 39 (60) 40 (51) 79 (55)
I am glad I found out the trial results4 Number for whom data were available for this outcome: 145
Strongly disagree 1 (2) 1 (1) 0.80 (0.39 to 1.67) p = 0.555 0.76 (0.36 to 1.62) p = 0.475 2 (1)
Slightly disagree 0 (0) 2 (3) 2 (1)
Neither 5 (8) 9 (11) 14 (10)
Slightly agree 13 (20) 12 (15) 25 (17)
Strongly agree 47 (71) 55 (70) 102 (70)
I regret finding out the trial results5 Number for whom data were available for this outcome: 138
Strongly disagree 48 (76) 53 (71) 1.51 (0.74 to 3.08) p = 0.253 1.51 (0.72 to 3.16) p = 0.279 101 (73)
Slightly disagree 7 (11) 5 (7) 12 (9)
Neither 8 (13) 13 (17) 21 (15)
Slightly agree 0 (0) 3 (4) 3 (2)
Strongly agree 0 (0) 1 (1) 1 (1)
I found the results upsetting Number for whom data were available for this outcome: 140
Strongly disagree 39 (61) 36 (47) 1.68 (0.87 to 3.23) p = 0.123 1.54 (0.79 to 3.00) p = 0.206 75 (54)
Slightly disagree 4 (6) 8 (11) 12 (9)
Neither agree nor disagree 14 (22) 16 (21) 30 (21)
Slightly agree 2 (3) 14 (18) 16 (11)
Strongly agree 5 (8) 2 (3) 7 (5)
1Adjusted for strata, randomisation phase (early vs late), and clustering.
2Adjusted for age, education level, and internet use as well as strata, randomisation phase (early vs late), and clustering.
3For producing the ORs for this variable, the strongly and slightly disagree categories were merged.
4For calculating the ORs, the strongly disagree, slightly disagree, and neither agree nor disagree categories were merged for this variable.
5For calculating the ORs, the neither agree nor disagree, slightly agree, and strongly agree categories were merged for this variable.
aOR, adjusted OR; OR, odds ratio; uOR, unadjusted OR.
https://doi.org/10.1371/journal.pmed.1003798.t006
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Tables 4–6 shows the OR and CIs by intervention, and S6 Table gives details of those who
reported finding out the results by randomised intervention and subgroup. Of the 3 interven-
tions, only the Mailed Printed Summary significantly increased the odds of finding out the
results among those who wanted to know the results, with 78/83 (94%) reporting finding out
the results, compared to 67/81 (83%) of those in the no Mailed Printed Summary arms, an OR
of 3.57 (95% CI 1.18 to 10.77, p = 0.024), adjusted for age, education level, internet use, strata,
randomisation phase, and clustering. No participants subscribed to the email list. Further
information on the uptake of the interventions can be found in S2 Text, and qualitative find-
ings around participants’ desire for the results can be found in S3 Text.
Did the information tell participants everything they wanted to know?
Most participants agreed that the information told them everything they wanted to know
(Tables 4–6). Participants at sites allocated to the Enhanced Webpage were more likely to
agree that the information told them everything they wanted to know (adjusted OR 2.15, 95%
CI 1.13 to 4.07, p = 0.019) than those allocated to the Basic Webpage. There were no significant
differences between the Mailed Printed Summary versus No Mailed Printed Summary, or
Email List Invitation versus No Email List Invitation. See S3 Text for qualitative findings relat-
ing to this outcome.
Was the information understandable?
Approximately 80% of participants reported that they found the results easy to understand.
There was no statistically significant difference in any of the randomised comparisons for this
outcome (Tables 4–6). See S3 Text for qualitative findings relating to this outcome.
Was the information easy to find?
Quantitative results on whether the information was easy to find. Almost three-quar-
ters of participants reported easily finding the results, with no significant differences between
any of the Show RESPECT interventions for this outcome (Tables 4–6).
Qualitative findings on whether the information was easy to find. The Mailed Printed
Summaries were seen as accessible to everyone, as they were not reliant on people’s computer
literacy or access to the internet.
“Like my mum, for instance, in her 80s, she wouldn’t have access to this [webpage], so she
would only want . . . She would only be able to have posted results, really.” GMI02
When asked whether there were other ways in which they would have liked to have received
the results, 22/91 (24%) questionnaire respondents from hospitals not randomised to the
Mailed Printed Summary said they would have liked to receive the results by mail, with mail
being seen as convenient and easier to access.
Rarely, questionnaire respondents reported not having been told how to access the results.
It is unclear whether or not they received the Patient Update Information Sheet (which site
logs record as having been sent). Others (from sites not randomised to the Mailed Printed
Summary) reported receiving the Patient Update Information Sheet but missed the informa-
tion on how to obtain the results that the sheet contained. About 11/180 questionnaire respon-
dents reported difficulties accessing the webpage, either not having access to computers, or
finding it hard to get onto the webpage, with some participants eventually gaining access,
alone or with the help of family members, and others not succeeding. One woman decided to
not try to access the results if it meant going online. Other participants, who had been able to
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access the results themselves, were concerned that sharing results via webpages/email alone
would be inaccessible to other participants, either because of lack of computer literacy or lack
of access to the internet.
“We live in quite a small community here in [County] but there’s several people that aren’t
computer literate. And I think to presume that everybody has got access to web pages and
what have you would be a mistake. And also, even things like the bandwidth or whatever you
call it here is dire. Sometimes our connection is awful and I still know people in [County] who
can’t get a connection so if they’re going to have to go to Costa Coffee to get connected to find
out the results of a trial, that doesn’t feel very comfortable.” DLI01
One patient commented that the process of having to type in a URL from the Patient
Update Information Sheet to get to the webpage was a barrier to accessing the results, and she
would have preferred to be sent them by email without having to visit a webpage to sign up for
the email list.
How did patients react to finding out the results?
While 127/145 (88%) of participants reported being glad they had found out results, only 4/
138 (3%) reported regretting finding the results. About 23/140 (16%) of participants strongly
or slightly agreed that they found the results upsetting, which is higher than the proportion
regretting finding out the results, suggesting that while some participants were upset by the
results, they did not regret having received them. There was no statistically significant differ-
ence between the arms on any of these outcomes (Tables 4–6). See S3 Text for qualitative find-
ings around participants’ emotional responses to the results.
What did patients think about the communication interventions?
S7 Table summarises the qualitative feedback from questionnaires and interviews on the inter-
ventions tested within Show RESPECT.
What were patients’ attitudes to trial participation and the ICON8 results?
With no evidence of difference between the Show RESPECT interventions (Table 7), 131/146
(90%) of respondents reported being willing to take part in future research, and 132/147 (90%)
said they were likely to recommend taking part in research to others. See S3 Text for qualita-
tive findings around participants’ attitudes to the research.
Discussion
The Show RESPECT study demonstrated that sharing results with trial participants via Mailed
Printed Summaries in addition to webpages increased participant satisfaction with how the
results were communicated compared to webpages alone, and also enabled more participants
who wanted to know the results to find them out. This satisfaction was due to the clear and
understandable nature of the results summaries, ease of access, using their preferred approach,
the two-stage process used, and the perceived impact of the trial (despite its “negative” results).
Among women taking part in an ovarian cancer treatment trial, nearly all wanted to know the
overall trial results. None of the participants who did not want to know the results found them
out. It is important to look at these outcomes (satisfaction among those who received results,
and proportions of people who wanted or did not want the results who received them)
together, as they may not necessarily have pointed in the same direction. The two-stage
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process, informing participants that the results are available and how to access them, rather
than automatically sending results out to all participants, was important to ensure that the
wishes of the 7% of participants who did not want to find out the results were respected. This
may be especially important in trials where the participant population may be vulnerable, or
the results may be emotionally challenging for some participants. The additional features of
the Enhanced Webpage did not increase satisfaction with how the results were communicated
compared to the Basic Webpage but did lead to a higher proportion of participants reporting
that it told them everything they wanted to know. The lack of uptake of the Email List Invita-
tion suggests that for similar trial populations, it is not worth creating email lists at the end of
the trial.
The qualitative findings show that participants liked the Mailed Printed Summary as an
approach, as it was seen as more accessible for patients with limited access to the internet or
computer literacy, and it also facilitated keeping the results for future reference, or showing to
friends and family. The results sparked a range of responses, including both positive emotions
and disappointment and upset, but there was no evidence to suggest that they were experi-
enced as harmful by these individuals, and nearly all participants were glad to have received
the results, even if some had found them upsetting.
Table 7. Reported outcomes relating to take part in or recommend taking part in research.


























How willing are you to take part in future research?5 Number for whom data were available for this outcome: 146
Very
unwilling
1 (1) 2 (3) uOR: 0.77 (0.37 to
1.62) p = 0.494 aOR:
0.80 (0.38 to 1.70)
p = 0.567
3 (5) 0 (0) uOR: 1.11 (0.54 to
2.30) p = 0.777 aOR:
1.09 (0.52 to 2.28)
p = 0.827
2 (3) 1 (1) uOR: 0.72 (0.34 to
1.51) p = 0.380 aOR:





1 (1) 1 (1) 1 (2) 1 (1) 1 (1) 1 (1) 2 (1)
Not sure 6 (8) 4 (5) 2 (3) 8 (10) 3 (4) 7 (9) 10 (7)
Quite
willing




10 (15) 15 (19) 25 (17)
Very
willing




51 (76) 55 (70) 106 (73)
How likely are you to recommend taking part in research to others?6 Number for whom data were available for this outcome: 147
Very
unlikely
3 (4) 3 (4) uOR: 1.13 (0.55 to
2.31) p = 0.739 aOR:
1.17 (0.56 to 2.44)
p = 0.671
5 (7) 1 (1) uOR: 1.28 (0.63 to
2.62) p = 0.491 aOR:
1.23 (0.59 to 2.57)
p = 0.579
2 (3) 4 (5) uOR: 0.82 (0.40 to
1.69) p = 0.594 aOR:





1 (1) 1 (1) 0 (0) 2 (3) 1 (1) 1 (1) 2 (1)
Not sure 6 (8) 1 (1) 2 (3) 5 (6) 4 (6) 3 (4) 7 (5)
Quite
likely




11 (16) 17 (21) 28 (19)




49 (73) 55 (69) 104 (71)
1Adjusted for strata, randomisation phase (early vs late), and clustering.
2Adjusted for age, education level, and internet use as well as strata, randomisation phase (early vs late), and clustering.
3Adjusted for age, education level, and internet use as well as strata, randomisation phase (early vs late), and clustering.
4For producing the ORs for this variable, the strongly and slightly disagree categories were merged.
5For calculating the ORs, the very unwilling, quite unwilling, and not sure were merged for this variable.
6 For calculating the ORs, the very unlikely, quite unlikely, and not sure were merged for this variable.
aOR, adjusted OR; uOR, unadjusted OR.
https://doi.org/10.1371/journal.pmed.1003798.t007
PLOS MEDICINE Testing approaches to sharing trial results with participants: the Show RESPECT cRCT
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003798 October 4, 2021 19 / 26
Our trial employed a cluster randomised factorial design to assess 3 methods of sharing
results with participants, allowing us to be confident that the differences observed were due to
the interventions. Extensive PPI was carried out to ensure that the study was asking a question
that was important to patients and that the interventions tested were appropriate. The inter-
ventions selected were designed to be easily replicable in other studies. The mixed methods
approach allowed us to explore the reasons behind the quantitative results, while gaining an
overall picture across the study population.
Budget constraints meant that we were unable to send questionnaires to all ICON8 partici-
pants at the participating sites. However, we used random selection of participants to avoid
selection bias, and the characteristics of respondents in terms of age and ICON8 arm are simi-
lar to that of all eligible participants at trial sites. Our response rate of those invited to complete
the questionnaire was 65%. This introduces uncertainty into the interpretation of our results,
as we do not know how outcomes would vary between responders and nonresponders. How-
ever, our response rate is similar to that seen in other studies looking at communication of
results to trial participants [8,38]. We cannot discern if there are differences between respon-
dents and nonrespondents in other potentially relevant characteristics (e.g., education level,
computer literacy); however, respondents cover the range of these characteristics, and the sub-
group analysis showed no evidence of heterogeneity in effect by these subgroups. We do not
have data on the ethnicity of participants in either the host ICON8 trial or the embedded Show
RESPECT trial, meaning that we cannot assess whether ethnicity influences desire to know
trial results, or how these results should be shared. We are also unable to explore the impact of
what respondents’ first language was on their experience of receiving results. Future clinical
trials of treatment may wish to systematically collect this information up front to assess inclu-
sivity [39] and facilitate embedded trials, like Show RESPECT.
This randomised controlled trial contributes to the, as yet, scant evidence base on how to
communicate study results to trial participants, providing high-quality evidence to a field that
is dominated by observational data, surveys asking about hypothetical scenarios, and expert
opinion. Our study adds comparative data around the effectiveness of different communica-
tion approaches in practice. Our results around participants’ desire for results are consistent
with findings from previous studies [4]. Our participants’ positive reaction to receiving trial
results is also consistent with that reported by previous studies [17,18,20,22], even in the con-
text of potentially upsetting results [23]. Box 1 lists our recommendations on points for trialists
to consider around sharing results with trial participants.
Show RESPECT was conducted within the context of an ovarian cancer treatment trial,
where the population was women with an average age of 67 years and living in the UK. It is
unclear how generalizable these results are to trials with different patient populations (e.g., all
male or mixed, younger participants and participants likely more familiar with technology, tri-
als studying non-life-threatening conditions, or where results are available soon after receiving
trial treatment). Webpages are a low-cost communication approach and may be useful along-
side printed summaries, giving opportunities to provide links to further information and sup-
port, and audiovisual content that Printed Summaries cannot provide. However, 4 in 10 of our
respondents reported using the internet or email less than daily, with 15% never using them.
Data from the UK Office for National Statistics in 2019 show that 10% of the UK population
are classed as internet nonusers, having either never used the internet or not used it in the last
3 months [40]. Internet nonusers in the UK are more likely to be women, over the age of 65,
have a disability, or be economically inactive (particularly those on long-term sick leave) [40].
Households with lower incomes are also less likely to have an internet connection [40]. While
the number of internet nonusers has been declining in recent years, trials should be careful
about relying on the internet or email to share results with participants if their trial population
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overlaps with some of the groups most likely to be internet nonusers. Failure to take this into
account could exclude a significant proportion of participants from accessing results. If trials
are to meet the ethical obligation to offer results to participants, they need to plan and budget
for this in a way that is accessible to the trial population. Trials with similar patient populations
should budget for Mailed Printed Summaries or ensure that alternative approaches to web-
pages are easily available and known to those participants for whom webpages are inaccessible.
Problems accessing the internet were not the only reasons participants preferred the printed
summaries; even those who use the internet daily were more likely to be satisfied with the
printed summary, which made it easy for participants to file along with other trial information
and to share with others.
Other trial settings may pose different challenges around sharing results; however, qualita-
tive research from the BRACELET study, which focused on neonatal intensive care trials,
found similar responses to the receipt of results among bereaved parents [41].
The ICON8 results that we were communicating (no difference between the trial regimens)
may have influenced participants’ reported satisfaction, interacting with the communication
interventions. The results of the ICON8 trial did not come out of the qualitative research as a
major reason for satisfaction or dissatisfaction with how they were shared, and most partici-
pants in the qualitative interviews understood the importance of “negative” trial results. How-
ever, our qualitative findings do raise the question of whether modified or tailored approaches
would be needed to communicate results to participants in each of the trial’s randomised
groups if the trial had found a strong clinical difference. People on the poorer performing arm
may need additional support or more personalised approaches to receiving results. All
Box 1. Recommendations based on this research.
• Trial teams should consider when planning their study how to share results with par-
ticipants, taking into account:
• the characteristics of the study population, including, but not limited to, health liter-
acy, computer literacy, access to the internet, age, and, likely, health status;
• the need to offer choice to participants, allowing those who want to find out the
results easy access but not forcing them on those who do not want to receive them;
and
• how to make it possible for participants to keep the results, so they can refer to them
in the future.
• Trial teams should adequately budget the necessary resources to fulfil their obligation
to offer the results to study participants in a way that is appropriate to the study popu-
lation—the lowest cost approaches (e.g., a basic webpage) may not be optimal for
every study population.
• Patient and public involvement is essential for planning how to share results with par-
ticipants, identifying the outcomes and study results that are important and relevant to
participants, and developing the content of results summaries.
• Care is needed to ensure that the wording of results summaries is both clear to partici-
pants and sensitively written.
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eventualities need to be anticipated if a feedback strategy is built into a trial protocol. Research
is needed to explore whether our results are reproducible in trials that do find significant bene-
fit or harm.
Future analysis of data collected within Show RESPECT will focus on the perspective of site
staff involved in sharing the results with participants, the process used for this, and resource
implications of the communication approaches used. Further research is needed to explore the
issue of sharing results with the relatives of trial participants who die during a trial, to see if
this is something that relatives want, and if so, how it can be done without causing unnecessary
distress.
Conclusions
There is a lot of evidence that trial participants want to be offered the overall results of their
trial. A common criticism is that there is not enough guidance as to how this might happen.
By testing a number of approaches in a sensitive area, and finding out what is acceptable to
participants, Show RESPECT moves the field forward. For the patient population of the
ICON8 ovarian cancer trial, adding Mailed Printed Summaries to web-based approaches
improved patient satisfaction and was better at ensuring those who wanted to know the results
were able to find them out. Box 1 contains recommendations based on this research.
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